Baramidze Anna

Baramidze Anna

Petre Shotadze Tbilisi Medical Academy - Tbilisi / Georgia
Others
AD Scientific Index ID: 4787688
თბილისის სამედიცინო აკადემია
person_outline Baramidze Anna's MOST POPULAR ARTICLES
1-) Cemiplimab plus chemotherapy versus chemotherapy alone in advanced NSCLC: 2-year follow-up from the phase 3 EMPOWER-lung 3 part 2 trial Journal of Thoracic Oncology 18 (6), 755-768, 2023
2-) Homocysteine and D-dimer levels and multilayer computed tomography for diagnosing pulmonary artery thromboembolism hospitals 3, 5, 2017
3-) A phase 3 trial of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus pembrolizumab in patients with previously untreated unresectable locally advanced or metastatic … Journal of Clinical Oncology 41 (16_suppl), TPS9602-TPS9602, 2023
4-) 114M0 First-line cemiplimab for locally advanced non-small cell lung cancer: Updated subgroup analyses from EMPOWER-Lung 1 and EMPOWER-Lung 3 Journal of Thoracic Oncology 18 (4), S106, 2023
5-) Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer with PD-L1≥ 1%: A subgroup analysis from the EMPOWER-Lung 3 part 2 trial Lung Cancer 193, 107821, 2024